| Hepatocellular Carcinoma |
1 |
1 |
| Cancer |
0 |
0.9 |
| Renal Cell Carcinoma |
0 |
0.64 |
| Biologic Therapy |
0 |
0.55 |
| Biliary Disease |
0 |
0.45 |
| Liver |
0 |
0.4 |
| Liver Disease |
0 |
0.35 |
| Tumor |
0 |
0.3 |
| Tyrosine Kinase Inhibitor |
0 |
0.99 |
| Angiogenesis Inhibitors |
0 |
0.2 |
| Gastrointestinal Hemorrhage |
0 |
0.2 |
| Humanized Monoclonal Antibody |
0 |
0.2 |
| Tyrosine Kinase |
0 |
0.2 |
| Vein |
0 |
0.2 |
| California |
0 |
0.1 |
| Cirrhosis |
0 |
0.1 |
| Clinical Research |
0 |
0.1 |
| Hospital |
0 |
0.1 |
| Palmar |
0 |
0.1 |
| Plantar |
0 |
0.1 |
| Thrombus |
0 |
0.1 |
| Vascular Endothelial Growth Factor |
0 |
0.1 |
| Healthcare and Medical Technology |
0 |
0.09 |
| Hypertension |
0 |
0.09 |
| Thromboembolism |
0 |
0.09 |